OVERVIEW

The Oncology Nurse’s Role in the Management of Head and Neck Cancer is organized by Med Learning Group.

Dates:
Release Date: December 16, 2019
Expiration Date: December 16, 2020

Accreditation:
Credit Designation Statement
Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

Nursing Credit Information
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with head and neck cancer.
CNE Credits: 1.0 ANCC Contact Hour.

CNE Accreditation Statement
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hours of continuing nursing education for RNs and APNs.

Description:
This online activity will cover the treatment and management of patients with head and neck cancer.

Objectives:
On completing the program, attendees should be able to:
• Describe the dysregulation of the immune system that supports the development of SCCHN
• Review the mechanisms of action of immune-oncology therapies in patients with recurrent and metastatic SCCHN
• Discuss clinical trial-derived efficacy and safety data for immuno-oncology agents for use in patients with recurrent or metastatic SCCHN
• Explain how to recognize and manage immune check point inhibitor-associated immune-related adverse events in patients with SCCHN

Additional details will be posted as soon as information is available.